Baron Silver Stevens Financial Advisors, LLC Gilead Sciences, Inc. Transaction History
Baron Silver Stevens Financial Advisors, LLC
- $527 Million
- Q2 2024
A detailed history of Baron Silver Stevens Financial Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Baron Silver Stevens Financial Advisors, LLC holds 10,061 shares of GILD stock, worth $852,569. This represents 0.13% of its overall portfolio holdings.
Number of Shares
10,061
Previous 13,105
23.23%
Holding current value
$852,569
Previous $959,000
28.05%
% of portfolio
0.13%
Previous 0.19%
Shares
11 transactions
Others Institutions Holding GILD
# of Institutions
1,878Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$10.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$9.77 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.46 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.12 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.03 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $106B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...